Stock screener

OBIO

Conviction 64HealthcareScan · Mon, Aug 10, 2026
OBIO$4.47+5.42%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
2
Vol MA14 175.72K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Orchestra BioMed Holdings, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.orchestrabiomed.com
Price4.47
Change+5.42%
Gap+1.65%
Rel volume1.64×
Avg volume191.14K
Avg $ vol743.94K
SMA 203.90
SMA 503.98
SMA 2004.17
Price vs 50+12.42%
Price vs 200+7.18%
MA stackmixed
50/200 cross
Supertrendup · 3.80
RSI (14)68
MACD hist0.07
MACD crossbull · 9d
Stoch %K / %D97 / 91
ADX (14)20
+DI / −DI26 / 11
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.34%
ADR %4.46%
52w high5.35
52w low2.35
From 52w high-16.45%
Above 52w low+90.21%
New 52w highNo
SqueezeOff
Bollinger width25.69%
%B1.06
Donchian pos97.34%
Donchian high4.50
Donchian low3.56
AVWAP (52w high)4.18
vs AVWAP high+6.86%
AVWAP (52w low)4.05
vs AVWAP low+10.30%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d1.64×
Avg vol (14d)175.72K
Avg vol (20d)191.14K
Avg $ vol (20d)743.94K
Market cap268.67M
RS 3m (vs SPY)+2.19%
RS 6m (vs SPY)+0.17%
RS line new highNo
Trend template6/8
Technical rank76.4
1 week+8.50%
1 month+12.03%
3 months+10.64%
6 months+14.32%
1 year+71.92%
YTD+3.71%
P/E-5.10
P/B2.69
P/S8.02
P/FCF-5.43
EPS-1.11
Div yield
ROE-52.83%
ROA-45.55%
Debt/Eq0.15
Current8.26
EV/EBITDA-5.11
Gross margin
Net margin-157.40%
Rev growth1169.22%
EPS growth13.64%
Price target
Target upside
Analyst rating
Institutional
Ent. value263.2M
Revenue88K
Net income-23.75M
Gross profit
Free cash flow-49.45M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out59.88M
Employees86
ListedFri, Jan 27, 2023
Free float29.71M
Float %49.6%
Short interest2.59M
Days to cover10.9d
Short volume69.0%
Squeeze score71 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeB
Conviction64 / 100
Pattern quality
Tech rank76.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance4.54
Support3.58
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OBIO

All disclosures →
No recent disclosed trades by Congress in OBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OBIO · 6 buys · 4 sells

InsiderSideShares
Cleary Chris
Director · Common Stock, par value $0.0001 per share · 2026-06-24
Tax3.51K
Fain Eric S
Director · Common Stock · 2026-06-24
Tax4.26K
Mack John Prosper
Director · Common Stock · 2026-06-24
Tax3.51K
Pacitti David
Director · Common Stock · 2026-06-24
Tax3.78K
Connealy Pamela Ann
Director · Stock Option (Right to Buy) · 2026-06-23
Grant21.28K
Fain Eric S
Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23
Grant17.33K
Pacitti David
Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23
Grant17.33K
Fain Eric S
Director · Stock Option (Right to Buy) · 2026-06-23
Grant21.28K
Mack John Prosper
Director · Common Stock, par value $0.0001 per share ("Common Stock") · 2026-06-23
Grant34.65K
Pacitti David
Director · Stock Option (Right to Buy) · 2026-06-23
Grant21.28K

SEC filings

EDGAR filings in OBIO · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.